Dans l’attente de l’actualisation des objectifs MT - SOUS-REVUE vs ACHAT - OC s.r (vs 2,6€)
La société annonçait hier matin un changement stratégique qui se traduit par la mise en sommeil de la filiale US et le remplacement d’Yves Vignancour par Pierre Dumouchel en tant que Directeur Général par intérim. Cette décision stratégique de réallocation des moyens sur l’Europe et les pays émergents est en grande partie la résultante du ralentissement observé des ventes sur le marché américain au T4 15. Les coûts induits à cette fermeture sont considérés comme « très faibles ». En conclusion, « SafeOrthopaedics ne sera toutefois pas en mesure de tenir son objectif de 10 000 chirurgies annuelles en 2017, qui intégrait une forte croissance aux États-Unis ». En attendant de plus amples détails le 28 avril prochain (résultats annuels 2015 et CA T1 16), nous mettons notre objectif de cours et recommandation sous revue.Safe Orthopaedics SAS. Safe Orthopaedics SA is a France-based company principally engaged in the medical devices industry. The Company focuses on the development and commercialization of products for use in spinal surgery. It provides a range of implants and ready to use instrument kits. The Company's product portfolio comprises SteriSpine PS, which is the Pedicle Screw System; and SteriSpine LC, which is the Lumbar Cage System that enables safe implant positioning, as well as access, insertion and placement of the implant. The Company's products are equipped with quick change handle, dual trial and impact removal, among others. The Company mainly uses polyarylamid material, which is a polymar with 50% glass fibers.
Since 2006, Invest Securities has become one of the leading players in investment services for funds and managers, to whom we offer a global and personalised service. Our track record differentiates us and proves our leadership in numerous promising sectors like property and growth companies.
Consisting of 13 different profiles (pharmacist, engineer, financier, etc), the DNA of our financial analysis office is value added and sector expertise. Through daily monitoring and detailed analyses of companies and sectors, we seek to provide a differentiating vision of our 120 stocks followed. Our ideas are circulated every day to nearly 1,000 professionals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.